Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene

Lancet

Volumn 347, Issue 8994, 1996, Pages 88-91

  Stewart, Paul M ^a   Krozowski, Zygmunt S ^c   Gupta, Amrit ^a   Milford, David V ^b   Howie, Alex J ^a   Sheppard, Michael C ^a   Whorwood, Christopher B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; DNA; ENZYME ANTIBODY; MINERALOCORTICOID; MUTANT PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CHILD; CONTROLLED STUDY; ENDOCRINE DISEASE; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXON; HETEROZYGOTE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; PLACENTA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; STILLBIRTH; STOP CODON;

EID: 0030049329     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90211-1     Document Type: Article

References (30)

1. Shackleton CHL, Stewart PM. The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri EG, Melby JC, eds. Endocrine hypertension. New York: Raven Press, 1990; 155-73.
2. Ulick S, Levine LS, Gunczler P, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979; 49: 757-64.
3. Monder C, White PC. 11β-hydroxysteroid dehydrogenase. Vitam Norm 1993; 47: 187-271.
4. Arriza JL, Weinberger C, Cerelli G, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor Science 1987; 237: 268-75.
5. Edwards CRW, Stewart PM, Burt D, et al. Localisation of 11β-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 1988; ii: 986-89.
6. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583-85.
7. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase comes of age. Lancet 1987; ii: 821-84.
8. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW. The mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci 1990; 78: 49-54.
9. Dimartino-Nardi J, Stonor E, Martin K, Balfe JW, Jose PA, New MI. New findings in apparent mineralocorticoid excess. Clin Endocrinol 1987; 27: 49-62.
10. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. The syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 1988; 82: 340-49.
11. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11β-hydroxysteroid dehydrogenase. Structure, tissue distribution and chromosome localization. J Biol Chem 1991; 266: 16653-58.
12. Whorwood CB, Mason JI, Rickctts ML, Howie AJ, Stewart PM. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using RT-PCR and localization of the type 2 isoform to renal collecting ducts. Mol Cell Endocrinol 1995; 110: R7-R12.
13. Brown RW, Chapman KE, Edwards CRW, Seckl JR. Human placental 11β-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology 1993; 132: 2614-21.
14. Stewart PM, Murry BA, Mason JI. Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type 1 isoform. J Clin Endocrinol Metab 1994; 79: 480-84.
15. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type II enzyme. Mol Cell Endocrinol 1994; 105: R11-R17.
16. Agarwal AK, Mune T, Monder C, White PC. NAD-dependent isoform of 11β-hydroxysteroid dehydrogenase: cloning and characterization of cDNA from sheep kidney. J Biol Chem 1994; 269: 25959-962.
17. Milford DV, Shackleton CHL, Stewart PM. Mineralocorticoid hypertension and congenital deficiency of 11β-hydroxysteroid dehydrogenase in a family with the syndrome of "apparent" mineralocarticoid excess. Clin Endocrinol 1995; 43: 242-46.
18. Stewart PM, Rogerson F, Mason JI. Type 2 11β-hydroxysteroid dehydrogenase in human placenta and fetal membranes; its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 1995; 80: 885-90.
19. Krozowski ZS, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localisation of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 1995; 80: 2203-09.
20. Krozowski ZS, Baker E, Obeyesekere V, Callen DF. Localisation of the gene for human 11β-hydroxysteroid dehydrogenase type 2 enzyme to chromosome 16q22. Cytogenet Cell Genet 1995; 71: 124-25.
21. Werder E, Zachmann M, Vollmin JA, et al. Unusual steroid excretion in a child with low-renin hypertension. Res Steroids 1974; 6: 385-89.
22. Souness GW, Morris DJ. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomised rat. Endocrinology 1989; 124: 1588-90.
23. Nikkila H, Tannin GM, New MI, et al. Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxo-reductase deficiency. J Clin Endocrinol Metab 1993; 77: 687-91.
24. Wilson RC, Krozowski ZS, Li K, et al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995; 80: 2263-66.
25. Edwards CRW, Benediktsson R, Lindsay RS, Seckl JS. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 1993; 341: 355-57.
26. Kitanaka S, Tane A, Tanaka T, Hibi I. A Japanese case of apparent mineralocorticoid excess. Proceedings of 77th annual meeting of the Endocrine Society; June 1995; Washington, DC. p2-188.
27. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262-65.
28. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β-subunit of the epithelial sodium channel. Cell 1994; 79: 407-14.
29. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol 1993; 39: 221-227.
30. Soro A, Ing ram M, Tonolo G, Glorioso N, Fraser R. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 1995; 25: 67-70.